Simten Dağdaş
Simten Dağdaş publishes mostly in Hematology, Genetics and Immunology, on topics such as Myeloproliferative Neoplasms: Diagnosis and Treatment, Multiple Myeloma Research and Treatments and Chronic Myeloid Leukemia Treatments.
- World rank
- #1,501,947 of 1,633,909 ranked researchers
- Rank in Türkiye
- #15,149 of 17,160
- Works
- 17
- Citations
- 8
- Citations per work
- 0.5
What does Simten Dağdaş research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Hematology27% of their works
- 2Genetics13% of their works
- 3Immunology7% of their works
- 4Public Health, Environmental and Occupational Health7% of their works
- 5Pulmonary and Respiratory Medicine7% of their works
- 6Radiology, Nuclear Medicine and Imaging7% of their works
Research topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Immunodeficiency and Autoimmune Disorders
- Biosimilars and Bioanalytical Methods
- Oral and gingival health research
- Poisoning and overdose treatments
Which keywords describe Simten Dağdaş's research?
The keywords of their largest research topics: BCR-ABL, Diagnosis Criteria, Imatinib, International Myeloma Working Group, JAK2 Mutation, Myelofibrosis, Protease-Activated Receptors and Thrombin.
- Toxic Exposure Surveillance
- Poison Control Centers
- Gingival Overgrowth
- Drug-Induced
- Thrombin
- Myelofibrosis
- International Myeloma Working Group
- Diagnosis Criteria
- BCR-ABL
- Imatinib
- JAK2 Mutation
- Protease-Activated Receptors
- Biosimilars
- Genetic Mutations
- Immunogenicity
- Primary Immunodeficiency
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- BCR-ABL21 topic
- Diagnosis Criteria21 topic
- Imatinib21 topic
- International Myeloma Working Group21 topic
- JAK2 Mutation21 topic
- Myelofibrosis21 topic
- Protease-Activated Receptors21 topic
- Thrombin21 topic
- Biosimilars11 topic
- Drug-Induced11 topic
- Genetic Mutations11 topic
- Gingival Overgrowth11 topic
- Immunogenicity11 topic
- Poison Control Centers11 topic
- Primary Immunodeficiency11 topic
- Toxic Exposure Surveillance11 topic
Where does Simten Dağdaş work?
Simten Dağdaş's main affiliation in the publication record is Memorial Ankara Hospital, Türkiye.
How many publications and citations does Simten Dağdaş have?
Science Explorer counts 17 works and 8 citations for Simten Dağdaş, ranking #1,501,947 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.